Literature DB >> 29982468

Predicting Risk of Postoperative Disease Recurrence in Crohn's Disease: Patients With Indolent Crohn's Disease Have Distinct Whole Transcriptome Profiles at the Time of First Surgery.

Kelly C Cushing1, Richard Mclean1, Keely G McDonald1, Jenny K Gustafsson1, Kathryn A Knoop1, Devesha H Kulkarni1, R Balfour Sartor2, Rodney D Newberry1.   

Abstract

Background: Assessing risk of Crohn's disease (CD) recurrence following ileocolic resection (ICR) is necessary to optimize medical management and prevent long-term complications. This study aimed to identify noninvasive markers that could predict postoperative disease activity.
Methods: Inclusion criteria were a diagnosis of CD, first ICR, interval colonoscopy, and whole transcriptome array meeting quality control standards. Demographic and clinical data were obtained from the electronic medical record. RNA extraction and human transcriptome microarray were performed on noninflamed ileal margins from operative specimens. Clinical data and random forest were analyzed in R. Principal components analysis, hierarchical clustering, and pathway enrichment were performed in Partek.
Results: Sixty-five patients completed the study, and 5 were excluded from analysis due to extreme variability on whole transcriptome analysis. Unsupervised hierarchical clustering revealed that patients with an i0 Rutgeerts score generally segregated from all others. In anti-TNF-naïve patients, unsupervised hierarchical clustering revealed complete segregation of patients with an i0 score. Reduced escalation in therapy and continued mucosal remission, consistent with indolent disease, were seen in the 4 years following surgery. Random forest identified 30 transcripts differentiating i0 patients from the other groups. Pathway enrichment highlighted toll-like receptor, NOD-like receptor, and TNF signaling. This transcriptome signature did not identify i0 anti-TNF-exposed patients. However, anti-TNF-exposed patients with indolent postoperative courses were found to have a transcriptome signature distinct from those with aggressive disease. Conclusions: Anti-TNF-naïve and -exposed patients have unique expression profiles at the time of surgery, which may offer predictive value in assessing the risk of nonrecurrence. 10.1093/ibd/izy228_video1izy228.video15804852517001.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29982468      PMCID: PMC6354560          DOI: 10.1093/ibd/izy228

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  39 in total

1.  The association of cigarette smoking with a high risk of recurrence after ileocolonic resection for ileocecal Crohn's disease.

Authors:  T Yamamoto; M R Keighley
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Molecular cloning and characterization of Bif-1. A novel Src homology 3 domain-containing protein that associates with Bax.

Authors:  S M Cuddeback; H Yamaguchi; K Komatsu; T Miyashita; M Yamada; C Wu; S Singh; H G Wang
Journal:  J Biol Chem       Date:  2001-03-20       Impact factor: 5.157

3.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository.

Authors:  Ron Edgar; Michael Domrachev; Alex E Lash
Journal:  Nucleic Acids Res       Date:  2002-01-01       Impact factor: 16.971

4.  The colorectal microRNAome.

Authors:  Jordan M Cummins; Yiping He; Rebecca J Leary; Ray Pagliarini; Luis A Diaz; Tobias Sjoblom; Omer Barad; Zvi Bentwich; Anna E Szafranska; Emmanuel Labourier; Christopher K Raymond; Brian S Roberts; Hartmut Juhl; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

Review 5.  Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: a breakthrough in anticancer therapy?

Authors:  V Labi; F Grespi; F Baumgartner; A Villunger
Journal:  Cell Death Differ       Date:  2008-03-28       Impact factor: 15.828

6.  Tobacco use is associated with accelerated clinical recurrence of Crohn's disease after surgically induced remission.

Authors:  Sunanda V Kane; Michael Flicker; Flora Katz-Nelson
Journal:  J Clin Gastroenterol       Date:  2005-01       Impact factor: 3.062

7.  Predictors of Crohn's disease.

Authors:  Laurent Beaugerie; Philippe Seksik; Isabelle Nion-Larmurier; Jean-Pierre Gendre; Jacques Cosnes
Journal:  Gastroenterology       Date:  2006-03       Impact factor: 22.682

8.  The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies.

Authors:  George E Reese; Theodore Nanidis; Catherine Borysiewicz; Takayuki Yamamoto; Timothy Orchard; Paris P Tekkis
Journal:  Int J Colorectal Dis       Date:  2008-09-02       Impact factor: 2.571

Review 9.  A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn's disease.

Authors:  Constantinos Simillis; Takayuki Yamamoto; George E Reese; Satoru Umegae; Koichi Matsumoto; Ara W Darzi; Paris P Tekkis
Journal:  Am J Gastroenterol       Date:  2007-09-25       Impact factor: 10.864

10.  Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study.

Authors:  Inger Camilla Solberg; Morten H Vatn; Ole Høie; Njaal Stray; Jostein Sauar; Jørgen Jahnsen; Bjørn Moum; Idar Lygren
Journal:  Clin Gastroenterol Hepatol       Date:  2007-12       Impact factor: 11.382

View more
  7 in total

Review 1.  Artificial Intelligence for Disease Assessment in Inflammatory Bowel Disease: How Will it Change Our Practice?

Authors:  Ryan W Stidham; Kento Takenaka
Journal:  Gastroenterology       Date:  2022-01-04       Impact factor: 22.682

Review 2.  Machine Learning Predictive Outcomes Modeling in Inflammatory Bowel Diseases.

Authors:  Aamir Javaid; Omer Shahab; William Adorno; Philip Fernandes; Eve May; Sana Syed
Journal:  Inflamm Bowel Dis       Date:  2022-06-03       Impact factor: 7.290

3.  Clinical applications of artificial intelligence and machine learning-based methods in inflammatory bowel disease.

Authors:  Shirley Cohen-Mekelburg; Sameer Berry; Ryan W Stidham; Ji Zhu; Akbar K Waljee
Journal:  J Gastroenterol Hepatol       Date:  2021-02       Impact factor: 4.029

Review 4.  Artificial Intelligence Enhances Studies on Inflammatory Bowel Disease.

Authors:  Guihua Chen; Jun Shen
Journal:  Front Bioeng Biotechnol       Date:  2021-07-08

5.  Development of a prognostic model for one-year surgery risk in Crohn's disease patients: A retrospective study.

Authors:  Jia-Yin Yao; Yi Jiang; Jia Ke; Yi Lu; Jun Hu; Min Zhi
Journal:  World J Gastroenterol       Date:  2020-02-07       Impact factor: 5.742

Review 6.  Machine Learning Modeling from Omics Data as Prospective Tool for Improvement of Inflammatory Bowel Disease Diagnosis and Clinical Classifications.

Authors:  Biljana Stankovic; Nikola Kotur; Gordana Nikcevic; Vladimir Gasic; Branka Zukic; Sonja Pavlovic
Journal:  Genes (Basel)       Date:  2021-09-18       Impact factor: 4.096

Review 7.  Big data in IBD: big progress for clinical practice.

Authors:  Nasim Sadat Seyed Tabib; Matthew Madgwick; Padhmanand Sudhakar; Bram Verstockt; Tamas Korcsmaros; Séverine Vermeire
Journal:  Gut       Date:  2020-02-28       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.